Immunocore and Pulse Infoframe announced a partnership to support a global patient registry in uveal melanoma, according to a press release.
Institutions from the United States, the United Kingdom and Australia will participate in the registry, which will examine risk factors, genetics, epidemiology, treatment cost-effectiveness and real-world outcomes.
“We’re excited to be working with the research community to address the need for a more comprehensive understanding of uveal melanoma,” Mohammed Dar, MD, head of clinical development and chief medical officer at Immunocore,
Uncategorized